CpG oligodeoxynucleotides as vaccine adjuvants in primates

Area of Science:

• Immunology
• Vaccinology
• Primate Models

Background:

• Synthetic oligodeoxynucleotides (ODN) with unmethylated CpG motifs are potent immune adjuvants in mice.
• CpG ODN that stimulate human peripheral blood mononuclear cells (PBMC) show limited efficacy in mice, necessitating alternative animal models.
• Evaluating human-specific CpG ODN requires an animal model that mirrors human immune responses.

Purpose of the Study:

• To determine if rhesus macaques recognize and respond to human-activating CpG motifs.
• To assess the efficacy of CpG ODN as an immune adjuvant in a non-human primate model.
• To validate rhesus macaques as a suitable preclinical model for human CpG ODN.

Main Methods:

• Administration of synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs to rhesus macaques.
• Coadministration of CpG ODN with a heat-killed Leishmania vaccine.
• Challenge of macaques with cutaneous Leishmania infection to assess vaccine efficacy.

Main Results:

• Rhesus macaques demonstrated recognition and immune response to the same CpG motifs that activate human immune cells.
• Coadministration of CpG ODN with the Leishmania vaccine significantly enhanced protection against cutaneous Leishmania infection in macaques.
• CpG ODN acted as a strong immune adjuvant in this primate model.

Conclusions:

• Rhesus macaques provide a relevant animal model for studying the in vivo activity and safety of human CpG motifs.
• CpG ODN are effective immune adjuvants in rhesus macaques, supporting their potential in human vaccine development.
• This study validates the use of CpG ODN as a promising adjuvant strategy for vaccines targeting infectious diseases.